Indian Patent Act Amendments Vote

22 September 1996

The long-awaited legislation amending India's 1970 Patent Act will be brought by the government in the winter session of parliament, which begins in the third week of November, according to Commerce Secretary Tejendra Khanna, speaking at a conference in New Delhi attended by foreign investors and diplomats. The amendments will enable India to comply fully with the obligations of World Trade Organization membership.

The announcement was welcomed by the USA, which has moved the WTO dispute settlement mechanism against India because of its failure to comply with patent obligations.

Mr Khanna also told the meeting that a political process of educating the constituents of the 13-party United Front government on the patent issue is currently underway, and that the Prime Minister has also held a number of meetings with political leaders.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight